Literature DB >> 28544945

Longitudinal association between diabetes and cognitive decline: The National Health and Aging Trends Study.

Alexandra M V Wennberg1, Clinton E Hagen2, Rebecca F Gottesman3, Vadim Zipunnikov4, Christopher N Kaufmann5, Marilyn S Albert3, George W Rebok6, Judith D Kasper7, Adam P Spira8.   

Abstract

Type II diabetes mellitus (DM) is associated with increased risk of dementia; however, few studies have examined the longitudinal association between DM and cognitive outcomes in large nationally representative cohorts. We investigated these associations in 7605 participants enrolled in the National Health and Aging Trends Study, a nationally representative prospective study of Medicare beneficiaries ≥65, from 2011 to 2015. Participants or proxy respondents reported DM and dementia diagnosis, and participants completed immediate and delayed recall word list learning tests and the Clock Drawing Test. In multivariable-adjusted generalized linear mixed models, baseline DM diagnosis was associated with decline on immediate and delayed word recall and the Clock Drawing Test. In Cox proportional hazards models, DM also predicted incident dementia in older age groups at baseline. These findings further support the notion that DM is associated with cognitive outcomes, suggesting that treatment and prevention of DM may reduce the risk of these outcomes. However, more studies are needed to better understand whether DM treatments affect this relationship.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognitive decline; Dementia; Diabetes; Epidemiology

Mesh:

Year:  2017        PMID: 28544945      PMCID: PMC5967846          DOI: 10.1016/j.archger.2017.05.005

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  37 in total

1.  Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies.

Authors:  G Cheng; C Huang; H Deng; H Wang
Journal:  Intern Med J       Date:  2012-05       Impact factor: 2.048

2.  Incidence of dementia and cognitive impairment, not dementia in the United States.

Authors:  Brenda L Plassman; Kenneth M Langa; Ryan J McCammon; Gwenith G Fisher; Guy G Potter; James R Burke; David C Steffens; Norman L Foster; Bruno Giordani; Frederick W Unverzagt; Kathleen A Welsh-Bohmer; Steven G Heeringa; David R Weir; Robert B Wallace
Journal:  Ann Neurol       Date:  2011-03-18       Impact factor: 10.422

3.  Validity and reliability of self-reported diabetes in the Atherosclerosis Risk in Communities Study.

Authors:  Andrea L C Schneider; James S Pankow; Gerardo Heiss; Elizabeth Selvin
Journal:  Am J Epidemiol       Date:  2012-09-25       Impact factor: 4.897

4.  NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study.

Authors:  P K Elias; M F Elias; R B D'Agostino; L A Cupples; P W Wilson; H Silbershatz; P A Wolf
Journal:  Diabetes Care       Date:  1997-09       Impact factor: 19.112

Review 5.  Cognitive dysfunction in patients with type 2 diabetes.

Authors:  Yael D Reijmer; Esther van den Berg; Carla Ruis; L Jaap Kappelle; Geert Jan Biessels
Journal:  Diabetes Metab Res Rev       Date:  2010-10       Impact factor: 4.876

6.  Accuracy of self-reported anthropometric measures in older Australian adults.

Authors:  Maria Pasalich; Andy H Lee; Linda Burke; Jonine Jancey; Peter Howat
Journal:  Australas J Ageing       Date:  2013-05-13       Impact factor: 2.111

7.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

8.  Glucose levels and risk of dementia.

Authors:  Paul K Crane; Rod Walker; Rebecca A Hubbard; Ge Li; David M Nathan; Hui Zheng; Sebastien Haneuse; Suzanne Craft; Thomas J Montine; Steven E Kahn; Wayne McCormick; Susan M McCurry; James D Bowen; Eric B Larson
Journal:  N Engl J Med       Date:  2013-08-08       Impact factor: 91.245

9.  Diabetes and cognitive outcomes in a nationally representative sample: the National Health and Aging Trends Study.

Authors:  Alexandra M V Wennberg; Rebecca F Gottesman; Christopher N Kaufmann; Marilyn S Albert; Lenis P Chen-Edinboro; George W Rebok; Judith D Kasper; Adam P Spira
Journal:  Int Psychogeriatr       Date:  2014-07-30       Impact factor: 3.878

Review 10.  Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis.

Authors:  Feng-Ping Lu; Kun-Pei Lin; Hsu-Ko Kuo
Journal:  PLoS One       Date:  2009-01-07       Impact factor: 3.240

View more
  5 in total

Review 1.  Diabetes-Specific Dementia: A Structured Literature Review of Cognitive Assessment Methods.

Authors:  Kelli L Faaitiiti; Daniel C Jupiter
Journal:  J Foot Ankle Surg       Date:  2021-11-14       Impact factor: 1.286

2.  Type 2 diabetes mellitus and cognitive decline in older adults in Germany - results from a population-based cohort.

Authors:  Kun Xie; Laura Perna; Ben Schöttker; Matthias Kliegel; Hermann Brenner; Ute Mons
Journal:  BMC Geriatr       Date:  2022-05-26       Impact factor: 4.070

3.  Predictors of cognitive decline in a multi-racial sample of midlife women: A longitudinal study.

Authors:  Jasmine S Dixon; Alice E Coyne; Kevin Duff; Rebecca E Ready
Journal:  Neuropsychology       Date:  2021-05-20       Impact factor: 3.424

4.  Cognitive Function in Adolescents and Young Adults With Youth-Onset Type 1 Versus Type 2 Diabetes: The SEARCH for Diabetes in Youth Study.

Authors:  Allison L B Shapiro; Dana Dabelea; Jeanette M Stafford; Ralph D'Agostino; Catherine Pihoker; Angela D Liese; Amy S Shah; Anna Bellatorre; Jean M Lawrence; Leora Henkin; Sharon Saydah; Greta Wilkening
Journal:  Diabetes Care       Date:  2021-04-26       Impact factor: 17.152

5.  Glycemic Dysregulations Are Associated With Worsening Cognitive Function in Older Participants at High Risk of Cardiovascular Disease: Two-Year Follow-up in the PREDIMED-Plus Study.

Authors:  Carlos Gómez-Martínez; Nancy Babio; Jordi Júlvez; Nerea Becerra-Tomás; Miguel Á Martínez-González; Dolores Corella; Olga Castañer; Dora Romaguera; Jesús Vioque; Ángel M Alonso-Gómez; Julia Wärnberg; José A Martínez; Luís Serra-Majem; Ramón Estruch; Francisco J Tinahones; José Lapetra; Xavier Pintó; Josep A Tur; José López-Miranda; Aurora Bueno-Cavanillas; José J Gaforio; Pilar Matía-Martín; Lidia Daimiel; Vicente Martín-Sánchez; Josep Vidal; Clotilde Vázquez; Emilio Ros; Søren Dalsgaard; Carmen Sayón-Orea; José V Sorlí; Rafael de la Torre; Itziar Abete; Lucas Tojal-Sierra; Francisco J Barón-López; Noelia Fernández-Brufal; Jadwiga Konieczna; Antonio García-Ríos; Emilio Sacanella; M Rosa Bernal-López; José M Santos-Lozano; Cristina Razquin; Andrea Alvarez-Sala; Albert Goday; M Angeles Zulet; Jessica Vaquero-Luna; Javier Diez-Espino; Aida Cuenca-Royo; Fernando Fernández-Aranda; Mònica Bulló; Jordi Salas-Salvadó
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-29       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.